<DOC>
	<DOCNO>NCT03033069</DOCNO>
	<brief_summary>To evaluate safety , efficacy tolerability brexpiprazole ( placebo ) monotherapy combination therapy ( Zoloft ) adult PTSD .</brief_summary>
	<brief_title>A Study Flexible Dose Brexpiprazole Monotherapy Combination Therapy Treatment Adults With Post-traumatic Stress Disorder</brief_title>
	<detailed_description>This trial design assess efficacy , safety tolerability flexible dose brexpiprazole monotherapy combination therapy Zoloft ( Sertraline ) adult subject PTSD . This study consist continuous 12-week , double-blind treatment period 14-day follow-up .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Brexpiprazole</mesh_term>
	<criteria>Male Female subject year 1865 diagnosis PTSD ( diagnosis make screen ) Index trauma event &gt; 15 year screen Index trauma event age &lt; 16 Any traumatic event within 3 month screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>